BUTRANS (buprenorphine) 5mcg/hr, 10mcg/hr, 20mcg/hr transdermal patch by Purdue Purdue announced that Butrans (buprenorphine) Transdermal System will be available for ordering the week of January 10, ...

BUTRANS (buprenorphine) 7.5mcg/hr Transdermal System by Purdue Purdue Pharma announced that it has received FDA approval for a new 7.5mcg/hour dosage strength of Butrans (buprenorphine) Transdermal ...

Transdermal buprenorphine (Norspan, Mundipharma) relieves diabetic neuropathic pain in patients who can stomach it, new research shows. Results from the 12-week, multicenter, double-blind, ...

Purdue Pharma L.P. Receives FDA Approval for 7.5 mcg/hour Dosage Strength of Butrans® (Buprenorphine) Transdermal System CIII FDA also approves the use of two Butrans patches for dose adjustments in ...

September 28, 2010 (Las Vegas, Nevada) — A transdermal application system containing the partial μ-opioid receptor agonist buprenorphine showed analgesic efficacy in the treatment of low back pain in ...

Purdue Pharma has received the US Food and Drug Administration (FDA) approval for a new 15 mcg/hour dosage strength of Butrans (buprenorphine) Transdermal System CIII, which will provide an additional ...

GREENFIELD, Ind.--(BUSINESS WIRE)--With the U.S. Food and Drug Administration (FDA) approval of Zorbium™ (buprenorphine transdermal solution), Elanco Animal Health (NYSE: ELAN) expands its pain ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. An error has occurred. Please try again ...

At a PAINWeek 2012 presentation investigators reported that immediate-release opioids are acceptable to use as supplemental analgesia in certain situations, according to the Monthly Prescribing ...

STAMFORD, Conn., Sept. 24, 2013 /PRNewswire/ -- Purdue Pharma L.P. announced that the U.S. Food and Drug Administration (FDA) approved a new 15 mcg/hour dosage strength of Butrans® (buprenorphine) ...

At a PAINWeek 2012 presentation investigators reported that immediate-release opioids are acceptable to use as supplemental analgesia in certain situations, according to the Monthly Prescribing ...

FDA issues approval for new, prescription medication to control postoperative pain associated with surgical procedures in cats, expanding Elanco’s pain portfolio. A new long-acting medication to ...